Key facts
- This page summarizes Anne-Virginie Eggimann's Form 4 filing for bluebird bio, Inc. (BLUE).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 14 Jul 2022, 16:15.
Anne-Virginie Eggimann - 12 Jul 2022 Form 4 Insider Report for bluebird bio, Inc. (BLUE)
- Reporting relationship
- Chief Regulatory Officer
- Issuer ticker
- BLUE
- Reported as of
- 12 Jul 2022
- Net transaction value
- -$6,722
- SEC form
- 4
- Accepted by SEC
- 14 Jul 2022, 16:15:49 UTC
- Prior SEC filing
- 21 Jun 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Helen C. Fu, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Anne-Virginie Eggimann filed Form 4 for bluebird bio, Inc. (BLUE) on 14 Jul 2022.
Change
- Previous filing in this sequence was filed on 21 Jun 2022.
- Current net transaction value: -$6,722.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BLUE
transaction
Common Stock
Sale
- Transaction value
- $6,722
- Shares
- -1,358
- Change %
- -3.1%
- Price
- $4.95
- Shares after
- 42,252
- Date
- 12 Jul 2022
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.